Towa Pharmaceutical Co., Ltd.
4553.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥49,576 | ¥35,015 | ¥45,471 | ¥29,252 |
| Short-Term Investments | ¥0 | ¥17,923 | ¥0 | ¥0 |
| Receivables | ¥56,934 | ¥58,758 | ¥71,631 | ¥68,318 |
| Inventory | ¥118,505 | ¥112,708 | ¥108,287 | ¥109,103 |
| Other Curr. Assets | ¥30,969 | ¥28,359 | ¥21,917 | ¥31,102 |
| Total Curr. Assets | ¥255,984 | ¥252,763 | ¥247,306 | ¥237,775 |
| Property Plant & Equip (Net) | ¥170,809 | ¥169,470 | ¥168,423 | ¥165,864 |
| Goodwill | ¥26,234 | ¥27,223 | ¥28,115 | ¥29,306 |
| Intangibles | ¥17,222 | ¥17,292 | ¥17,727 | ¥17,986 |
| Long-Term Investments | ¥963 | ¥862 | ¥1,377 | ¥846 |
| Tax Assets | ¥0 | ¥0 | ¥6,037 | ¥0 |
| Other NC Assets | ¥9,316 | ¥7,621 | ¥1,838 | ¥7,227 |
| Total NC Assets | ¥224,544 | ¥222,468 | ¥223,517 | ¥221,229 |
| Other Assets | ¥2 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥480,530 | ¥475,231 | ¥470,823 | ¥459,004 |
| Liabilities | – | – | – | – |
| Payables | ¥16,022 | ¥18,378 | ¥30,041 | ¥30,561 |
| Short-Term Debt | ¥29,598 | ¥27,969 | ¥24,105 | ¥15,569 |
| Tax Payable | ¥4,060 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥39,998 | ¥41,864 | ¥27,446 | ¥42,632 |
| Total Curr. Liab. | ¥91,282 | ¥89,651 | ¥87,939 | ¥78,689 |
| LT Debt | ¥192,069 | ¥196,529 | ¥195,077 | ¥197,083 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥4,325 | ¥4,375 | ¥4,378 | ¥4,533 |
| Total NC Liab. | ¥209,386 | ¥212,860 | ¥211,256 | ¥211,292 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥14,596 | ¥13,396 | ¥13,184 | ¥10,827 |
| Total Liabilities | ¥300,668 | ¥302,511 | ¥299,195 | ¥289,981 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥4,717 | ¥4,717 | ¥4,717 | ¥4,717 |
| Retained Earnings | ¥156,747 | ¥151,046 | ¥150,502 | ¥146,140 |
| AOCI | ¥16,140 | ¥14,702 | ¥14,149 | ¥15,909 |
| Other Equity | ¥1 | ¥0 | ¥2 | ¥2 |
| Total Equity | ¥179,862 | ¥172,720 | ¥171,625 | ¥169,023 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥480,530 | ¥475,231 | ¥470,823 | ¥459,004 |
| Net Debt | ¥172,091 | ¥189,483 | ¥173,711 | ¥183,400 |